Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Weight-Loss drug cagrilintide shows promise in Late-Stage trial

NCT ID NCT07220642

Ongoing Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 4 times

Summary

This Phase 3 trial tests whether cagrilintide, a new injectable drug, helps people with overweight or obesity lose weight. About 300 adults will receive either cagrilintide or a placebo for up to 18 months, along with lifestyle counseling. The study measures weight change and waist size reduction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cagrilintide
What this could lead to
If successful, cagrilintide could become a new weight-loss medication for people with overweight or obesity.
What could go wrong
This is a Phase 3 trial, but results may not match real-world use. Side effects are possible, and not everyone may lose significant weight.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY OVERWEIGHT

Contacts and locations

Locations

  • A.O.U. Bologna_ Policlinico S.Orsola Malpighi

    Bologna, 40138, Italy

  • AOUP Giaccone Palermo

    Palermo, Sicily, 90127, Italy

  • Brunel Medical Practice

    Torquay, Devon, TQ1 4QX, United Kingdom

  • CEDIC Centro de Investigación Clínica

    CABA, C1060ABA, Argentina

  • CIPREC Pueyrredon

    Buenos Aires, C1119ACN, Argentina

  • Care Clinic Sp. z o. o.

    Katowice, 40-568, Poland

  • Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec

    Saint-Herblain, 44800, France

  • Centre de Recherche Clinique Portes Du Sud

    Vénissieux, 69200, France

  • Centricity Research Mirabel

    Mirabel, Quebec, J7J 2K8, Canada

  • Centricity Research Oshawa

    Oshawa, Ontario, L1J 2K9, Canada

  • Centricity Research Toronto

    Toronto, Ontario, M4G 3E8, Canada

  • Diablo Clinical Research, Inc.

    Walnut Creek, California, 94598, United States

  • Drammen sykehus - Vestre Viken HF

    Drammen, 3004, Norway

  • Florida Inst For Clin Res LLC

    Orlando, Florida, 32825, United States

  • Fondazione Policlinico Universitario Agostino Gemelli IRCS

    Rome, RM, 00168, Italy

  • G.A. Research Associates Ltd.

    Moncton, New Brunswick, E1G 1A7, Canada

  • Hamilton Medical Research Group

    Hamilton, Ontario, L8L 5G4, Canada

  • Haukeland Universitetssykehus

    Bergen, 5021, Norway

  • Hunter Diabetes Centre

    Merewether, New South Wales, 2291, Australia

  • IRCCS Ospedale San Raffaele Milano

    Milan, 20132, Italy

  • InnoDiab Forschung GmbH

    Essen, 45136, Germany

  • Midwest Inst For Clin Res

    Indianapolis, Indiana, 46260, United States

  • Milestone Research

    London, Ontario, N5W 6A2, Canada

  • NBR Polska Tomasz Klodawski

    Warsaw, 00-710, Poland

  • North Coast Medical Ltd

    Newquay, Cornwall, TR7 1RU, United Kingdom

  • Nova Scotia Hlth Halifax

    Halifax, Nova Scotia, B3H 1V7, Canada

  • Oak Tree Surgery

    Liskeard, Cornwall, PL14 3XA, United Kingdom

  • Osteo-Medic s.c. A. Racewicz, J. Supronik

    Bialystok, 15-351, Poland

  • Oviedo Medical Research, LLC

    Oviedo, Florida, 32765, United States

  • PharmQuest Life Sciences LLC

    Greensboro, North Carolina, 27408, United States

  • RED-Institut für medizinische Forschung und Fortbildung GmbH

    Oldenburg in Holstein, 23758, Germany

  • Selma Medical Associates

    Winchester, Virginia, 22601-3834, United States

  • St. Olavs Hospital HF_Endokrinologisk avdeling

    Trondheim, NO-7030, Norway

  • StudyMetrix Research LLC

    City of Saint Peters, Missouri, 63303, United States

  • Sydney Cardiometabolic Centre

    Liverpool, New South Wales, 2170, Australia

  • Terpa Sp. z o.o. Sp. k.

    Lublin, 20-333, Poland

  • Univ of Colorado at Denver

    Aurora, Colorado, 80045, United States

  • Walgreens - Store 11760

    Oak Park, Illinois, 60302, United States

  • Wendisch - Dahl Hamburg - DZHW

    Hamburg, 22607, Germany

  • Wharton Medical Clinic Clinical Trials (Hamilton)

    Hamilton, Ontario, L8L 5G8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.